BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 2406808)

  • 1. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary changes in progressive systemic sclerosis].
    Yao WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Jun; 13(3):157-9, 191. PubMed ID: 2249319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary functions in children with progressive systemic sclerosis.
    Garty BZ; Athreya BH; Wilmott R; Scarpa N; Doughty R; Douglas SD
    Pediatrics; 1991 Dec; 88(6):1161-7. PubMed ID: 1956732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary manifestations of scleroderma and mixed connective tissue disease.
    Hant FN; Herpel LB; Silver RM
    Clin Chest Med; 2010 Sep; 31(3):433-49. PubMed ID: 20692538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac and pulmonary involvement in scleroderma].
    Launay D; Hachulla E
    Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis].
    Savarino E; Ghio M; Marabotto E; Zentilin P; Sammito G; Cittadini G; Sconfienza L; Murolo C; Gemignani L; Indiveri F; Savarino V
    Recenti Prog Med; 2009 Nov; 100(11):512-6. PubMed ID: 20066883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary involvement in progressive systemic sclerosis].
    Grisanti M; Vicencio M
    Rev Med Chil; 1986 Oct; 114(10):1002-5. PubMed ID: 3575934
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lung impairment in systemic sclerosis].
    Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
    Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of scleroderma lung disease.
    Highland KB; Garin MC; Brown KK
    Semin Respir Crit Care Med; 2007 Aug; 28(4):418-29. PubMed ID: 17764059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collageno-vascular diseases and interstitial pulmonary fibrosis. An analysis of diagnostic tests].
    Baldi S; Rapellino M; Libertucci D; Obert R; Scappaticci E; Coni F; Revello F; Oliaro A; Botto-Micca F
    Minerva Med; 1987 Sep; 78(17):1277-80. PubMed ID: 3670681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
    Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; LemariƩ E; Diot P
    Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lung in autoimmune collagen vascular disease (A-CVD).
    Rhodes ML; Smith JD
    Heart Lung; 1977; 6(4):653-9. PubMed ID: 301521
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary function tests.
    Behr J; Furst DE
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lungs in systemic sclerosis (scleroderma): a review and new information.
    McCarthy DS; Baragar FD; Dhingra S; Sigurdson M; Sutherland JB; Rigby M; Martin L
    Semin Arthritis Rheum; 1988 May; 17(4):271-83. PubMed ID: 3068803
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessments of pulmonary involvement in patients with systemic sclerosis.
    Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
    Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.